U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 04:50:03 UTC 2023
Edited
by admin
on Sat Dec 16 04:50:03 UTC 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
74T7185BMM
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
INEBILIZUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
IMMUNOGLOBULIN G2, ANTI-(HUMAN CD19 (ANTIGEN)) (SYNTHETIC HUMAN MONOCLONAL MEDI-551 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN MONOCLONAL MEDI-551 .KAPPA.-CHAIN, DIMER
Common Name English
INEBILIZUMAB [JAN]
Common Name English
INEBILIZUMAB [MI]
Common Name English
INEBILIZUMAB [USAN]
Common Name English
inebilizumab [INN]
Common Name English
MEDI551
Code English
Inebilizumab [WHO-DD]
Common Name English
MEDI-551
Code English
Classification Tree Code System Code
EU-Orphan Drug EU/3/17/1856
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
FDA ORPHAN DRUG 490415
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
FDA ORPHAN DRUG 295209
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
FDA ORPHAN DRUG 299209
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
Code System Code Type Description
CAS
1299440-37-1
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
INN
9985
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
DRUG BANK
DB12530
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
DAILYMED
74T7185BMM
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
NCI_THESAURUS
C88283
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
FDA UNII
74T7185BMM
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
ChEMBL
CHEMBL2109334
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
USAN
AB-114
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
MERCK INDEX
m12210
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
WIKIPEDIA
INEBILIZUMAB
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
RXCUI
2373951
Created by admin on Sat Dec 16 04:50:03 UTC 2023 , Edited by admin on Sat Dec 16 04:50:03 UTC 2023
PRIMARY
From To
1_22 1_96
1_148 1_204
1_224 3_218
1_230 2_230
1_233 2_233
1_265 1_325
1_371 1_429
2_22 2_96
2_148 2_204
2_224 4_218
2_265 2_325
2_371 2_429
3_23 3_92
3_138 3_198
4_23 4_92
4_138 4_198
Glycosylation Type MAMMALIAN, AFUCOSYLATED
Glycosylation Link Type Site
N 1_301
N 2_301
Related Record Type Details
SUB_CONCEPT->SUBSTANCE
TARGET->LIGAND
B Cell-Depleting Anti-CD19 Antibody
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NON-GLYCOSYLATED(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL